UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 18, 2022
Accession Number:
0001104659-22-119524
Submission Type:
POS AM
CIK:
0001664106
Company Name:
LogicBio Therapeutics, Inc.
File Number:
333-234735